A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

Recruiting Observational Study
Keratoconus Ectasia Crosslinking Fuchs' Endothelial Dystrophy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 75
Sex
Any
Study type
Observational
Participants needed
168 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group I includes healthy subjects with normal appearing corneas, normal topography and pachymetry. Group II includes patients diagnosed as having mild, moderate or advanced keratoconus by our ophthalmology expert on the basis of topography and pachymetry. Group III includes heal…
Contacts

Fatima Clouser, MS

4077331679

fclouser@mgh.harvard.edu

CONTACT

Andy Yun, PhD

syun@partners.org

CONTACT